During the past decade, Retinal Consultants of San Antonio conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 15 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retinal Consultants of San Antonio" #1 sponsor was "Jaeb Center for Health Research" with 16 trials, followed by "Allergan" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "ThromboGenics" with 2 trials sponsored and "Ashvattha Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retinal Consultants of San Antonio" #1 collaborator was "National Eye Institute (NEI)" with 15 trials as a collaborator, "National Institutes of Health (NIH)" with 7 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 3 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Retinal Consultants of San Antonio" are "Diabetic Macular Edema" (10 trials), "Diabetic Retinopathy" (5 trials), "Proliferative Diabetic Retinopathy" (4 trials), "Macular Degeneration" (3 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Retinal Consultants of San Antonio" in a lesser frequency.

Most popular intervention types in "Retinal Consultants of San Antonio" are "Drug" (22 trials), "Other" (7 trials), "Procedure" (6 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ranibizumab" (3 trials), "Sham Procedure" (3 trials), "APL-2" (2 trials) and "Deferred aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retinal Consultants of San Antonio" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Retinal Consultants of San Antonio". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Retinal Consultants of San Antonio, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retinal Consultants of San Antonio, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".